Next Article in Journal / Special Issue
Strategy for Treating Motor Neuron Diseases Using a Fusion Protein of Botulinum Toxin Binding Domain and Streptavidin for Viral Vector Access: Work in Progress
Previous Article in Journal
The Cyanobacteria Derived Toxin Beta-N-Methylamino-L-Alanine and Amyotrophic Lateral Sclerosis
Previous Article in Special Issue
Targeted Secretion Inhibitors—Innovative Protein Therapeutics

Spider-Venom Peptides as Therapeutics

Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia
Author to whom correspondence should be addressed.
Toxins 2010, 2(12), 2851-2871;
Received: 16 November 2010 / Revised: 17 December 2010 / Accepted: 17 December 2010 / Published: 20 December 2010
(This article belongs to the Special Issue Toxins as Therapeutics)
Spiders are the most successful venomous animals and the most abundant terrestrial predators. Their remarkable success is due in large part to their ingenious exploitation of silk and the evolution of pharmacologically complex venoms that ensure rapid subjugation of prey. Most spider venoms are dominated by disulfide-rich peptides that typically have high affinity and specificity for particular subtypes of ion channels and receptors. Spider venoms are conservatively predicted to contain more than 10 million bioactive peptides, making them a valuable resource for drug discovery. Here we review the structure and pharmacology of spider-venom peptides that are being used as leads for the development of therapeutics against a wide range of pathophysiological conditions including cardiovascular disorders, chronic pain, inflammation, and erectile dysfunction. View Full-Text
Keywords: spider venom; peptide; therapeutics; drugs; drug discovery; cystine knot spider venom; peptide; therapeutics; drugs; drug discovery; cystine knot
Show Figures

Graphical abstract

MDPI and ACS Style

Saez, N.J.; Senff, S.; Jensen, J.E.; Er, S.Y.; Herzig, V.; Rash, L.D.; King, G.F. Spider-Venom Peptides as Therapeutics. Toxins 2010, 2, 2851-2871.

AMA Style

Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, King GF. Spider-Venom Peptides as Therapeutics. Toxins. 2010; 2(12):2851-2871.

Chicago/Turabian Style

Saez, Natalie J., Sebastian Senff, Jonas E. Jensen, Sing Yan Er, Volker Herzig, Lachlan D. Rash, and Glenn F. King. 2010. "Spider-Venom Peptides as Therapeutics" Toxins 2, no. 12: 2851-2871.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop